Quarterly Result21 Sept 2026, 06:43 pm
Symbiotec Pharmalab Declares Q1 FY27 Unaudited Results
AI Summary
Symbiotec Pharmalab Ltd's Board of Directors met on September 21, 2026, and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27). The company has enclosed the financial results along with the Limited Review Reports. The trading window for dealing in the company's securities will remain closed until 48 hours after this announcement. The results will also be published in newspapers as per SEBI regulations.
Key Highlights
- Board approved Q1 FY27 unaudited financial results.
- Results include standalone and consolidated figures.
- Limited Review Reports were provided by auditors.
- Trading window remains closed post-announcement.
Price Impact
More from SYMBIOTEC